<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Shuman, Jill</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Shah, Dipen</style></author><author><style face="normal" font="default" size="100%">Nielsen, Jens Cosedis</style></author><author><style face="normal" font="default" size="100%">Kirchhof, Paulus</style></author><author><style face="normal" font="default" size="100%">Mabo, Philippe</style></author><author><style face="normal" font="default" size="100%">de Chillou, Christian</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Catheter Ablation of Atrial Fibrillation</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2015</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2015-11-09 11:22:16</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">2-4</style></pages><abstract><style  face="normal" font="default" size="100%">Catheter ablation increasingly is being used to manage patients with atrial fibrillation. Symptomatic patients should be considered for ablation soon after antiarrhythmics have been unsuccessful. Patients should continue anticoagulation for 3 months following the procedure and should undergo postprocedure follow-up as suggested by published guidelines.</style></abstract><number><style face="normal" font="default" size="100%">28 suppl 2</style></number><volume><style face="normal" font="default" size="100%">15</style></volume></record></records></xml>